Houfeng Huang, Xuebin Zhang, Yi Xie, Yi Zhao, YuShi Zhang, Xinrong Fan. "Neoadjuvant treatment with disitamab vedotin monotherapy in patients with HER2-overexpressing muscle invasive bladder cancer (MIBC): An open-label, single-arm, phase II study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16584